How does Belsomra compare to Ambien? When it comes to treating insomnia, both Belsomra and Ambien are popular prescription medications that work by enhancing the effects of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain. However, there are several differences between the two that can influence a patient’s choice of medication. In this article, we will explore the similarities and differences between Belsomra and Ambien, focusing on their effectiveness, side effects, and usage guidelines.
Belsomra, also known as eszopiclone, is a newer medication that was approved by the FDA in 2014. It is a nonbenzodiazepine sedative-hypnotic, which means it belongs to a class of drugs that are structurally different from benzodiazepines, like Ambien. The main difference between the two is that Belsomra targets specific GABA receptors in the brain, while Ambien works by enhancing the activity of GABA across the entire central nervous system.
One of the key advantages of Belsomra over Ambien is its lower risk of abuse and dependence. Belsomra has a lower potential for misuse, as it does not produce the same euphoric effects as benzodiazepines. Additionally, Belsomra has a shorter half-life, which means it leaves the body more quickly and may lead to fewer side effects. Ambien, on the other hand, has a longer half-life and can cause drowsiness the next day, known as “next-day residual effect.”
In terms of effectiveness, both Belsomra and Ambien have been shown to improve sleep quality and duration for most patients with insomnia. However, Belsomra has been found to have a faster onset of action, with some patients experiencing relief within 15 minutes. Ambien, on the other hand, may take longer to take effect, typically around 30 minutes.
When it comes to side effects, both medications can cause drowsiness, dizziness, and headache. However, Belsomra is less likely to cause next-day residual effects and has a lower risk of dependence and abuse. Ambien may also cause more vivid dreams, known as “sleep paralysis,” and is more likely to cause amnesia, or memory loss, during sleep.
Usage guidelines for Belsomra and Ambien also differ. Belsomra is typically taken once a day, around 30 minutes before bedtime, and is not recommended for long-term use. Ambien is usually taken once a day, but it can be taken at bedtime or earlier in the evening to minimize next-day drowsiness. Both medications should be taken with caution, as they can increase the risk of falls and accidents, especially in the elderly.
In conclusion, Belsomra and Ambien are both effective treatments for insomnia, but they differ in their mechanisms of action, potential side effects, and usage guidelines. Belsomra may be a better choice for those who are concerned about the risk of dependence and abuse, as well as those who prefer a faster onset of action. However, it is important for patients to consult with their healthcare provider to determine the most suitable medication for their individual needs.
